You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 22, 2024

Details for New Drug Application (NDA): 020193


✉ Email this page to a colleague

« Back to Dashboard


NDA 020193 describes ELMIRON, which is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. Additional details are available on the ELMIRON profile page.

The generic ingredient in ELMIRON is pentosan polysulfate sodium. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pentosan polysulfate sodium profile page.
Summary for 020193
Tradename:ELMIRON
Applicant:Janssen Pharms
Ingredient:pentosan polysulfate sodium
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020193
Suppliers and Packaging for NDA: 020193
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ELMIRON pentosan polysulfate sodium CAPSULE;ORAL 020193 NDA Janssen Pharmaceuticals, Inc. 50458-098 50458-098-01 100 CAPSULE, GELATIN COATED in 1 BOTTLE (50458-098-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength100MG
Approval Date:Sep 26, 1996TE:RLD:Yes

Expired US Patents for NDA 020193

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharms ELMIRON pentosan polysulfate sodium CAPSULE;ORAL 020193-001 Sep 26, 1996 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.